Physician profile
Robert A Leonardi
NPI 1013182898
$203,328.52
in general payments reported to CMS, 2019-2025
37 companies · $17K in 2025
The $17K reported for 2025 was more than what 92% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $14K · 2021: $63K · 2022: $55K · 2023: $8,880 · 2024: $18K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Travel and Lodging: $7,717 · Food and Beverage: $5,696 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $29,112.50 |
| Travel and Lodging | $7,717.26 |
| Food and Beverage | $5,696.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $133,351.09 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Inari Medical, INC. | $41,368.03 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $17,417.10 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Watchman Access System |
| Abbott Laboratories | $6,423.08 | 2019-2025 | Mitraclip, Ultreon, Navitor |
| Medtronic, INC. | $1,063.09 | 2021-2025 | Corevalve Evolut R, Micra, Linq II |
| Novartis Pharmaceuticals Corporation | $931.17 | 2019-2024 | |
| Abiomed | $712.57 | 2024-2025 | Impella |
| W. L. Gore & Associates, INC. | $248.64 | 2023 | Gore Cardioform Septal Occluder |
| Cardiva Medical, INC. | $182.65 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire, Savvywire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $167.51 | 2021-2025 | Lifevest |
| Stryker Corporation | $148.29 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Amgen INC. | $139.21 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $115.78 | 2019-2021 | |
| Chiesi USA, INC. | $108.12 | 2019-2025 | Kengreal |
| Atricure, INC. | $105.20 | 2023-2025 | Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System, Atricure Cryoice Cryoablation System (Cryo2) |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $103.67 | 2019-2020 | |
| Shockwave Medical, INC | $95.52 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $64.56 | 2019-2025 | Eliquis, Camzyos |
| Alnylam Pharmaceuticals INC. | $53.40 | 2024-2025 | Onpattro |
| Biosense Webster, INC. | $44.51 | 2019-2025 | Carto 3 |
| Novo Nordisk INC | $42.00 | 2019-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $41.57 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $41.13 | 2019 | |
| Angiodynamics, INC. | $40.98 | 2024 | Alphavac |
| Arbor Pharmaceuticals, INC. | $39.15 | 2019 | |
| Cardiovascular Systems INC. | $38.89 | 2021-2022 | |
| Cordis US Corp. | $36.11 | 2024-2025 | Mynx Control Venous, Mynx Venous Vcd |
| Philips North America LLC | $35.02 | 2019-2024 | (Bq9) Coronary Ivus |
| Merck Sharp & Dohme LLC | $25.49 | 2021-2023 | Verquvo |
| Pfizer INC. | $24.45 | 2019 | |
| Biotronik INC. | $24.35 | 2021 | |
| Bard Peripheral Vascular, INC. | $22.02 | 2023 | Venclose Maven Catheter |
| Irhythm Technologies, INC. | $18.67 | 2019 | |
| Impulse Dynamics (USA) INC. | $15.55 | 2022 | |
| Ekos Corporation | $13.84 | 2019 | |
| Kci USA, INC. | $13.19 | 2022 | |
| Amarin Pharma, INC. | $12.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Leonardi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.